UK Markets open in 3 hrs 24 mins

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.1500+0.0300 (+0.96%)
At close: 04:00PM EDT
3.1500 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 312.6100
52-week low 32.4600
50-day moving average 33.7160
200-day moving average 35.1727

Share statistics

Avg vol (3-month) 392.62k
Avg vol (10-day) 3153.22k
Shares outstanding 572.65M
Implied shares outstanding 6N/A
Float 832.15M
% held by insiders 152.11%
% held by institutions 119.48%
Shares short (28 Apr 2022) 4838.33k
Short ratio (28 Apr 2022) 411.05
Short % of float (28 Apr 2022) 42.13%
Short % of shares outstanding (28 Apr 2022) 41.00%
Shares short (prior month 30 Mar 2022) 4707.24k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-21.74%
Return on equity (ttm)-35.63%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-62.28M
EBITDA -78.67M
Net income avi to common (ttm)-75.11M
Diluted EPS (ttm)-1.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)173.84M
Total cash per share (mrq)2.12
Total debt (mrq)2.77M
Total debt/equity (mrq)1.29
Current ratio (mrq)14.86
Book value per share (mrq)2.46

Cash flow statement

Operating cash flow (ttm)-71.49M
Levered free cash flow (ttm)-44.78M